Plain-English translation of NCT06939374 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the CryoTherapy System (CTS), a device that uses freezing to treat dangerous plaque in your heart's blood vessels. You would receive this treatment if you've recently had a heart attack or severe chest pain and doctors have found high-risk plaque in another vessel that could become unstable. The study will follow you for one year to see if the freezing treatment helps stabilize the plaque and keeps it from causing future problems.
Some plaque in coronary arteries is unstable and more likely to rupture and cause another heart attack. This trial exists to test whether freezing therapy can make dangerous plaque more stable and reduce the risk of future cardiac events.
You likely qualify if…
You likely don't qualify if…
You will undergo a procedure where doctors thread a freezing catheter into your coronary arteries to treat the high-risk plaque. You'll have follow-up visits at 1, 3, 6, 9, and 12 months after the procedure, with detailed heart imaging (including special scans and angiography) at 9 months. The entire study participation lasts about one year, during which doctors will monitor you for any complications and measure whether the plaque has stabilized.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Belgium
United Kingdom